| OAA0105 | Are moto-neurons susceptible to SARS-CoV-2 infection? | Oral abstract session with live Q&A | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| OAA0405 | Protective efficacy of intranasal vaccination with a Sendai virus vector expressing a spike antigen against SARS-CoV-2 infection in mice | Oral abstract session with live Q&A | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| TUPEA12 | Pre-existing immunity restricts plasma and mucosal antibody responses during SARS-CoV-2 Omicron breakthrough infection | Poster exhibition | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| TUPEA13 | Immunological profiles of people living with HIV admitted with acute COVID-19 in Tshwane, South Africa | Poster exhibition | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPB0277 | Impact of COVID-19 pandemic on HIV viral load testing in paediatric HIV clinics in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0278 | Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): safety and immunogenicity analysis | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0279 | Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): Immunogenicity comparative analysis between one dose and two doses of Ad5-nCoV vaccine | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0280 | Assessing the Infection Prevention and Control Program during the COVID-19 era in the Health Facilities Participating in the COVIV (COVID/HIV) National Study in Mozambique, 2021-2022 | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0281 | Sex and sexually transmitted diseases in time of COVID: sexual behavior and incidence of gonorrhea and chlamydia in an HIV observational cohort in Thailand | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0282 | Post-acute sequelae of COVID-19 (PASC) and Quality of Life in people with HIV | E-poster | SARS-CoV-2, COVID-19 and HIV |